Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 15, 2015 - Issue 12
Submit an article Journal homepage
317
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Recent progress in urinary proteome analysis for prostate cancer diagnosis and management

Maria FrantziMosaiques diagnostics GmbH, Hannover, Germany;Biotechnology Division, Biomedical Research Foundation Academy of Athens, Athens, Greece
,
Agnieszka LatosinskaBiotechnology Division, Biomedical Research Foundation Academy of Athens, Athens, Greece
,
Axel S. MerseburgerDepartment of Urology, University of Lübeck, Lübeck, Germany
&
Harald MischakMosaiques diagnostics GmbH, Hannover, Germany;Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UKCorrespondence[email protected]
Pages 1539-1554 | Published online: 22 Oct 2015

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Maria Frantzi, Agnieszka Latosinska, Iwona Belczacka & Harald Mischak. (2019) Urinary proteomic biomarkers in oncology: ready for implementation?. Expert Review of Proteomics 16:1, pages 49-63.
Read now
Anna Mantsiou, Antonia Vlahou & Jerome Zoidakis. (2018) Tissue proteomics studies in the investigation of prostate cancer. Expert Review of Proteomics 15:7, pages 593-611.
Read now
Michael Harpole, Justin Davis & Virginia Espina. (2016) Current state of the art for enhancing urine biomarker discovery. Expert Review of Proteomics 13:6, pages 609-626.
Read now

Articles from other publishers (10)

Gabriela Schneider & Nichola C. Garbett. (2022) Sample Processing Considerations for Protein Stability Studies of Low Concentration Biofluid Samples using Differential Scanning Calorimetry. Protein & Peptide Letters 29:6, pages 485-495.
Crossref
Yan Feng, Shengzhi Liu, Rongrong Zha, Xun Sun, Kexin Li, Di Wu, Uma K. Aryal, Michael Koch, Bai-Yan Li & Hiroki Yokota. (2022) Prostate cancer-associated urinary proteomes differ before and after prostatectomy. Therapeutic Advances in Medical Oncology 14, pages 175883592211315.
Crossref
Amanda Khoo, Lydia Y. Liu, Julius O. Nyalwidhe, O. John Semmes, Danny Vesprini, Michelle R. Downes, Paul C. Boutros, Stanley K. Liu & Thomas Kislinger. (2021) Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry. Nature Reviews Urology 18:12, pages 707-724.
Crossref
Majid Assadi, Narges Jokar, Mojtaba Ghasemi, Iraj Nabipour, Ali Gholamrezanezhad & Hojjat Ahmadzadehfar. (2020) Precision Medicine Approach in Prostate Cancer. Current Pharmaceutical Design 26:31, pages 3783-3798.
Crossref
Anamika Gangwar, Shikha Jain, Subhojit Paul, Yasmin Ahmad & Kalpana Bhargava. (2019) Biofluids in hypobaric hypoxia: best possible use, investigative strategies and putative markers. Journal of Proteins and Proteomics 10:3, pages 191-206.
Crossref
Bo Yang, Guo-qiang Liao, Xiao-fei Wen, Wei-hua Chen, Sheng Cheng, Jens-Uwe Stolzenburg, Roman Ganzer & Jochen Neuhaus. (2017) Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer核磁共振波谱作为提高前列腺癌早期诊断和危险度分级的新方法. Journal of Zhejiang University-SCIENCE B 18:11, pages 921-933.
Crossref
Esther Nkuipou-Kenfack, Petra Zürbig & Harald Mischak. (2017) The long path towards implementation of clinical proteomics: Exemplified based on CKD273. PROTEOMICS - Clinical Applications 11:5-6, pages 1600104.
Crossref
Sílvia Barrabés, Noemi Farina-Gomez, Esther Llop, Angel Puerta, Jose Carlos Diez-Masa, Antoinette Perry, Rafael de Llorens, Mercedes de Frutos & Rosa Peracaula. (2017) Comparative analysis of prostate-specific antigen by two-dimensional gel electrophoresis and capillary electrophoresis. ELECTROPHORESIS 38:3-4, pages 408-416.
Crossref
Ming Xu, Li Zhang & Chaozhao Liang. (2016) Is it appropriate to conduct conventional active surveillance for Asian men with low-risk prostate cancer?. International Urology and Nephrology 48:8, pages 1287-1289.
Crossref
Anna Stepczynska, Joost P Schanstra & Harald Mischak. (2016) Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management. Bioanalysis 8:5, pages 439-455.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.